AGF-94

DB18023ExperimentalSmall molecule

AGF-94: Overview.

Mechanism: Pharmacologically active on Trifunctional purine biosynthetic protein adenosine-3
Curator reviewed
Formula / weight: C₁₉H₂₁N₅O₆S · 447.47 g/mol (avg)
Also known as: (5-(3-(2-amino-4-oxo-4,7-dihydro-3 h-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophene-2-carbonyl)-l-glutamic acid
Code names: AGF-94

Resolves to

Compound

UNIIX28K3E95TFCAS136784-51-5ChEMBLCHEMBL1834488

Structure

InChIKeyWMBYSCVMFMNUQV-LBPRGKRZSA-NSMILESNC1=NC2=C(C=C(CCCC3=CC=C(S3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2)C(=O)N1

Targets

P22102GART

Transporters

Q96NT5SLC46A1P15328FOLR1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3TransportersSubstrate / inhibitor direction, not just membership

Listed above

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with AGF-94, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In